Skip to main content
Skip to footer


 

ADD logo

 

Technology played a crucial role during the COVID-19 pandemic in ensuring smooth operations of clinical trials. The overhaul in the operations conducted on a digital platform in a unique phygital mode offered various advantages. It enabled shifting focus from site-centricity to patient centricity. Though overall timelines have been impacted through multiple protocol amendments as new design operation enablers, it has identified alternative approaches to aid virtual operations that are compliant with regulatory requirements. The whitepaper sheds light on how diverse technologies can be streamlined to improve clinical operations and identify and resolve the unmet needs of patients.

 

Author
Namrata Belekar
Picture

Namrata Belekar is an SME for TCS ADD Connected Clinical TrialsTM platform. She leads the platform on the decentralized clinical trials capabilities. Her contribution toward business proposals and data technology initiatives to build a robust features gamut is well-appreciated. In her 16-year career stint, she has handled Project Management, Data Management, and Statistics, managing full scope and standalone trials in therapeutic areas, including oncology, vaccines, diabetes, COPD and ophthalmology, to name a few.

Please fill the form or click here to download directly.

*Required field
*Enter valid First Name
*Required field
*Enter valid Last Name
*Required field
*Email syntax error
*Please use your business email.
*Required field
*Required field
*Enter valid company name
*Required field
*Required field
*Required field

Thank you
for your interest !!!
Welcome Back